NCT02888496View on ClinicalTrials.gov

Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Polymyalgia Rheumatica
Interventions
DRUG

tocilizumab

3 monthly IV infusions in PMR patients

Trial Locations (1)

29609

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT02888496 - Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica | Biotech Hunter | Biotech Hunter